MeCP2 epigenetically regulates alpha‐smooth muscle actin in human lung fibroblasts
- 1 March 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (7) , 3616-3625
Abstract
Background: A critical feature for fibroblasts differentiation into myofibroblasts is the expression of alpha‐smooth muscle actin (α‐SMA) during the tissue injury and repair process. The epigenetic mechanism, DNA methylation, is involved in regulating α‐SMA expression. It is not clear how methyl‐CpG‐binding protein 2 (MeCP2) interacts with CpG‐rich region in α‐SMA, and if the CpG methylation status would affect MeCP2 binding and regulation of α‐SMA expression.Methods: The association of MeCP2 with α‐SMA CpG rich region were examined by chromatin immunoprecipitation (ChIP) assays in primary fibroblasts from idiopathic pulmonary fibrosis (IPF) and non‐IPF control individuals, and in the lung fibroblasts treated with profibrotic cytokine transforming growth factor β1 (TGF‐β1). The regulation of α‐SMA by MeCP2 was examined by knocking down MeCP2 with small interfering RNA (siRNA). To explore the effects of the DNA methylation status of the CpG rich region on α‐SMA expression, the cells were treated with DNA methyltransferase inhibitor, 5′‐azacytidine (5′‐aza). The expression of α‐SMA was examined by Western blot and quantitative polymerase chain reaction, the association with MeCP2 was assessed by ChIP assays, and the methylation status was checked by bisulfate sequencing.Results: The human lung fibroblasts with increased α‐SMA showed an enriched association of MeCP2, while knockdown MeCP2 by siRNA reduced α‐SMA upregulation by TGF‐β1. The 5′‐Aza‐treated cells have decreased α‐SMA expression with reduced MeCP2 association. However, bisulfite sequencing revealed that most CpG sites are unmethylated despite the different expression levels of α‐SMA after being treated by TGF‐β1 or 5′‐aza.Conclusion: Our data indicate that the methyl‐binding protein MeCP2 is critical for α‐SMA expression in human lung myofibroblast, and the DNA methylation status at the CpG rich region of α‐SMA is not a determinative factor for its inducible expression.Keywords
Funding Information
- National Institute on Aging (R01AG050567)
This publication has 32 references indexed in Scilit:
- Participation of miR-200 in Pulmonary FibrosisThe American Journal of Pathology, 2012
- Essential Role of MeCP2 in the Regulation of Myofibroblast Differentiation during Pulmonary FibrosisThe American Journal of Pathology, 2011
- Epigenetic Regulation of Myofibroblast Differentiation by DNA MethylationThe American Journal of Pathology, 2010
- MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and FibrosisGastroenterology, 2010
- DNA methylation and methyl-CpG binding proteins: developmental requirements and functionChromosoma, 2009
- Recent advances in MeCP2 structure and functionThis paper is one of a selection of papers published in this Special Issue, entitled 29th Annual International Asilomar Chromatin and Chromosomes Conference, and has undergone the Journal’s usual peer review process.Biochemistry and Cell Biology, 2009
- Thy-1 Promoter HypermethylationAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genesProceedings of the National Academy of Sciences, 2007
- Enhanced Myofibroblastic Differentiation and Survival in Thy-1(−) Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2007